Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 9Erectile Dysfunction 9Sexuality 2Sexual Dysfunction, Physiological 2Rectal Neoplasms 2Neoplasms 2Fatigue 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Vascular Malformations 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Solid Tumor 1Sarcoma 1Radiation Injuries 1Pre-Eclampsia 1Postoperative Complications 1Penile Neoplasms 1Pancreatic Neoplasms 1Neurologic Manifestations 1Mental Fatigue 1Lymphoma, Follicular 1Lymphatic Abnormalities 1Lymphangioma 1Infertility 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Erectile Dysfunction Following Radical Prostatectomy 1Cholangiocarcinoma 1

Interventions

Rituximab 99Cyclophosphamide 63fludarabine phosphate 54Peripheral Blood Stem Cell Transplantation 52Mycophenolic Acid 33Bortezomib 33Whole-Body Irradiation 32ibrutinib 29Dexamethasone 27Tacrolimus 25Cyclosporine 25Etoposide 22Busulfan 22Melphalan 20Filgrastim 20Methotrexate 18Lenalidomide 18Antilymphocyte Serum 18Radiotherapy 16zanubrutinib 14Bendamustine Hydrochloride 14Sirolimus 13Calcium Dobesilate 11Everolimus 10venetoclax 9ibritumomab tiuxetan 9Prednisone 9Cyclosporins 9idelalisib 8Indium 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Waldenstrom Macroglobulinemia × Sildenafil Citrate × Clear all
NCT00165295 2011-06-27

Sildenafil Citrate in Waldenstrom's Macroglobulinemia

Dana-Farber Cancer Institute

Phase 2 Completed
30 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡